Related by context. All words. (Click for frequent words.) 60 Adjuvant chemotherapy 59 precancerous condition 59 perioperatively 58 breast endometrial 58 fibrocystic disease 57 Heavy menstrual bleeding 57 axillary dissection 57 Kattlove 57 undergoing hysterectomy 56 endometrial hyperplasia 56 Hormone pills 56 PCNSL 56 minimally symptomatic 56 breast uterine 56 gastric cardia 56 spontaneous regression 56 hypokalemia hypomagnesemia 56 cranial irradiation 56 impair fertility 56 nonmetastatic 56 BRCA deficient 56 antiestrogen therapy 56 testicular tumors 56 mutated K ras 56 advanced adenoma 56 aromatase inhibitor therapy 56 liver metastasis 55 abnormal Pap test 55 ovariectomy 55 unresectable tumors 55 taxane chemotherapy administered 55 overexpress HER2 55 pCR 55 pathologic fractures 55 undergo prostate biopsy 55 tumor histology 55 bilateral oophorectomy 55 neoadjuvant chemoradiotherapy 55 antiangiogenic therapy 55 adenomatous polyps 55 oral clodronate 55 biliary tract cancer 55 undergoing radical prostatectomy 55 endometrial biopsy 55 recurrent ovarian 55 relapsed ALL 55 invasive carcinoma 55 operable breast cancer 54 peritoneal cancer 54 nonischemic 54 refractory colorectal cancer 54 tumor subtype 54 radical prostatectomy RP 54 progestin therapy 54 recurrent glioblastoma multiforme 54 Ovary removal 54 hippocampal function 54 colon rectal 54 atypical ductal hyperplasia 54 inherited predisposition 54 perioperative morbidity 54 pathologic fracture 54 medically inoperable 54 nonalcoholic steatohepatitis NASH 54 lymph node removal 54 ovarian cervical 54 nonmelanoma skin cancers 54 type 1diabetes 54 prostate cancer CaP 54 axillary node dissection 54 orchiectomy 54 abnormal Pap smear 54 biochemical relapse 54 oral antidiabetes 54 Estrogen receptor positive 54 neutropenic sepsis 54 bowel resection 54 bowel polyps 53 NMIBC 53 undergoing coronary angiography 53 TNF blocker therapy 53 spontaneously regress 53 ovarian endometrial 53 silent ischemia 53 oophorectomy 53 Seewaldt 53 progesterone receptor negative 53 carotid artery blockage 53 colorectal adenoma 53 chemosensitivity 53 APOE genotype 53 stratifying patients 53 urinary bladder cancer 53 adjuvant radiation 53 Post operatively 53 inflammatory bowel syndrome 53 lobular cancer 53 colorectal adenomas 53 poststroke depression 53 salpingo oophorectomy 53 decompensated cirrhosis 53 arteriography 53 thromboembolisms 53 multi infarct dementia 53 diabetic kidney 53 postoperative atrial fibrillation 53 subclinical disease 53 transfusion syndrome 53 Clot busting 53 Garcia Manero 53 hereditary antithrombin deficient 53 prognostic indicators 53 afib 53 Colon polyps 53 epithelial ovarian 53 prophylactic mastectomies 53 androgen deprivation 53 precancerous polyp 53 premalignant lesions 53 gastro oesophageal reflux disease 53 antiarrhythmic medications 53 EGFR mutation positive 53 premenopausal 53 preoperative chemotherapy 53 BRCA2 mutation carriers 53 postoperative AF 53 induced neuropathy 53 hormone receptor status 53 abnormal mammograms 53 metastasized breast cancer 53 prostate cancer metastases 52 hormone deprivation 52 bony metastases 52 urothelial cancer 52 abnormal mammogram 52 MAGE A3 ASCI 52 colon polyp 52 underwent resection 52 Glioblastoma Multiforme GBM 52 nonvertebral fracture 52 mild renal insufficiency 52 aromatase inhibitors AIs 52 lung nodule 52 anthracycline taxane 52 spinal metastases 52 untreated celiac disease 52 Sentinel node biopsy 52 prostate cancer CRPC 52 NSCL cancer 52 Adjuvant therapy 52 thyroid nodules 52 perioperative complications 52 precancerous colon growths 52 debulking surgery 52 chemotherapy cisplatin 52 recurrent metastatic 52 nodal metastasis 52 lymph node biopsies 52 fibrocystic 52 intestinal polyps 52 postoperative radiotherapy 52 pelvic malignancies 52 subclinical cardiovascular disease 52 CSF biomarkers 52 adenoma detection 52 BRCA carriers 52 shorter telomere length 52 visit www.rtanswers.org 52 Menopausal hormone therapy 52 C1 INH deficiency 52 Legg Calvé Perthes disease 52 cutaneous melanoma 52 recurrent bladder 52 hormonally responsive 52 micro calcifications 52 hormonally sensitive 52 chemoembolization 52 pelvic lymphadenectomy 52 deep venous thromboses 52 androgen suppression therapy 52 cancerous polyp 52 peritoneal carcinomatosis 52 chronic myeloid 52 intravenous cyclophosphamide 52 adjuvant radiotherapy 52 PLX STROKE targeting 52 K ras mutations 52 inhaled bronchodilators 52 tamoxifen Nolvadex ® 52 arterial thickening 52 intermittent exotropia 52 univariate analyzes 52 completely resected 52 HER2 overexpression 51 premalignant lesion 51 chemoradiation therapy 51 cryptogenic 51 hMG 51 PSA nadir 51 Benign breast 51 HIV HCV coinfected 51 Dr. Puliafito 51 detecting precancerous 51 choroidal vasculopathy 51 neurocognitive dysfunction 51 KRAS mutation 51 hematopoietic cancers 51 postoperative delirium 51 varicocele 51 CR nPR 51 Prognostic factors 51 lumbar disk herniation 51 cranial radiation 51 ASCUS 51 estramustine 51 Chronic pancreatitis 51 micrometastases 51 potentially cancerous polyps 51 invasive lobular 51 acute lymphoblastic 51 BRCA mutation carriers 51 generalized anxiety disorder GAD 51 nodal metastases 51 hormone receptor negative 51 benign nodules 51 benign noncancerous 51 relapsed ovarian cancer 51 β blockers 51 FOLFIRI alone 51 symptom flare ups 51 prostate adenocarcinoma 51 cisplatin chemotherapy 51 malignant growths 51 Schaffir 51 cervical lymph node 51 nonmetastatic prostate cancer 51 CYP#D# genotype 51 thyroid hormone replacement 51 histologic subtype 51 methotrexate monotherapy 51 cerebral atrophy 51 histological subtype 51 resistant hormone refractory 51 hereditary predisposition 51 posttransplant 51 KRAS mutations 51 HNSCC 51 relapsed SCLC 51 surgical debulking 51 lobular carcinoma 51 visceral metastases 51 tumor recurrence 51 thyrotoxicosis 51 metastatic gastric 51 #Gy 51 Dr Zorbas 51 postoperative chemotherapy 51 INVEGA ™ 51 progression TTP 51 benign uterine 51 Angiotensin receptor blockers 51 refractory acute myeloid 50 curable cancers 50 biliary obstruction 50 de novo AML 50 lobular breast cancer 50 irinotecan chemotherapy 50 surgically resectable 50 benign ovarian 50 atypical hyperplasia 50 prolonged QT intervals 50 Hip fracture 50 noninvasive outpatient 50 adenomatous 50 chemotherapy docetaxel 50 malignant lesion 50 mammographic density 50 unresectable stage 50 antioxidant supplementation 50 #.#ng/ml 50 clinically localized prostate 50 testicular germ cell 50 Venous thromboembolism 50 multivariate adjustment 50 chemoresistant 50 metastatic ovarian cancer 50 autologous transplants 50 baseline mammogram 50 adjuvant cisplatin 50 basal cell skin 50 estrogen receptor negative 50 thromboembolic disease 50 androgen ablation 50 intravenous bisphosphonates 50 neuroblastoma tumor 50 circulating EPCs 50 avosentan 50 precancer 50 smoldering myeloma 50 cisplatin resistant 50 benign moles 50 ejaculatory dysfunction 50 ventricular dysfunction 50 adnexal mass 50 renal carcinoma 50 antiandrogen 50 unsightly veins 50 orchitis 50 K ras gene 50 beta blocker therapy 50 atypia 50 noncancer 50 GnRH agonists 50 axillary node 50 Scheuermann kyphosis 50 metastatic bladder 50 hamartoma 50 localized prostate 50 radioiodine therapy 50 artery reclogging 50 aerodigestive tract 50 neurologic progression 50 cisplatin gemcitabine 50 abnormal pap smear 50 invasive lobular carcinoma 50 polyp recurrence 50 recurrent atrial fibrillation 50 neurocognitive function 50 postop 50 metastatic GIST 50 treating neuropathic pain 50 CMV infections 50 euthyroid 50 FDG PET scans 50 LV dysfunction 50 Subgroup analyzes 50 hormone refractory 50 prostate carcinoma 50 overdiagnosing 50 thymoma 50 undergo mastectomy 50 breast cancer recurrences 50 anticoagulants blood thinners 50 pancreatic adenocarcinoma 50 benign lesion 50 convulsive disorders 50 ALND 50 noncardiovascular mortality 50 Stage IIIb 50 confidence interval #.#-#.# 50 papillary carcinoma 50 underactive thyroids 50 Hurthle cell 50 neurodevelopmental outcome 50 curative therapy 50 experimentally induced 50 dopamine antagonists 50 bilateral prophylactic mastectomy 50 precancerous tumors 50 adenoidectomy 50 poorer prognosis 50 ductal carcinomas 50 HER2 amplified 50 undergoing chemo 50 cervix uteri 50 saline infusion 50 postprocedure 50 KRAS mutation status 50 catheter angiography 50 endometrial carcinoma 50 Breast conserving 50 antiphospholipid antibodies 50 undergone hysterectomy 50 biologically predisposed 50 H. pylori infections 50 Hormone therapy 50 undergoing CABG 50 normal karyotype 50 FOLFOX4 49 spontaneous bacterial peritonitis 49 endometrial cancers 49 Cystoscopy 49 malignant ovarian 49 KRAS mutant tumors 49 Hormone Refractory Prostate Cancer 49 posttraumatic arthritis 49 androgen suppression 49 hepatic fibrosis 49 indolent lymphoma 49 ovarian carcinoma 49 Known hypersensitivity 49 colorectal neoplasms 49 elective PCI 49 thyroid carcinoma 49 needle aspiration 49 sentinel lymph node biopsy 49 clomipramine 49 Acute myeloid leukemia 49 castration resistant hormone refractory 49 Skin lesions 49 TMEM density 49 cancerous nodules 49 haematologic 49 Folfox 49 BRCA mutation 49 ductal breast cancer 49 stage IIIb IV 49 locoregional recurrence 49 Peritoneal mesothelioma 49 EXJADE 49 premature menopause 49 Randomized clinical trials 49 tamoxifen therapy 49 progressive dyspnea 49 rituximab refractory 49 tumor resection 49 Overdiagnosis 49 postoperative pulmonary 49 ductal cancer 49 EGFR mutation status 49 FGFR2 gene 49 BEXXAR Therapeutic Regimen 49 cervical lymph nodes 49 alveolar rhabdomyosarcoma 49 neurological abnormalities 49 immune suppressing medication 49 receiving TNF blockers 49 thrombotic complications 49 colorectal adenocarcinoma 49 dermatologic reactions 49 parathyroid 49 OSAHS 49 parkinsonian 49 palliative radiotherapy 49 neuroleptic 49 multivessel coronary artery 49 heavily pretreated 49 induce remission 49 fibroadenomas 49 core needle biopsies 49 5-fluorouracil/leucovorin 49 SOCS2 49 coronary CTA 49 adjuvant chemotherapy 49 relapsed AML 49 bronchopulmonary dysplasia 49 monozygotic twin 49 K ras mutation 49 defibrillator implant 49 cerebral oxygenation 49 undergoing coronary artery 49 abnormal vaginal bleeding 49 lung metastasis 49 neoplasias 49 advanced adenomas 49 cytoreductive surgery 49 weekly subcutaneous injections 49 sentinel node biopsy 49 neoadjuvant chemotherapy 49 myelogenous leukemia 49 metabolic dysregulation 49 Neoadjuvant 49 pancreatic lung 49 immunosuppressant medication 49 carotid stenosis 49 DXA scan 49 Surgical resection 49 fallopian tube carcinoma 49 mammograms MRIs 49 acute aortic dissection 49 underwent coronary angiography 49 ADVEXIN therapy 49 incidentalomas 49 bilateral salpingo oophorectomy 49 hyperplastic polyps 49 ocular melanoma 49 drank pomegranate juice 49 comorbid disorders 49 Randomized trials 49 benign proliferative breast 49 non hodgkin lymphoma 49 asymptomatic metastatic 49 edifoligide 49 clinically insignificant 49 mastalgia 49 absolute contraindication 49 colon resection 49 radiosensitive 49 limiting generalizability 49 asymptomatic carotid stenosis 49 bladder prostate 49 hepatic insufficiency 49 lowest tertile 49 % CI #.#-#.# [008] 49 Selective serotonin reuptake inhibitors 49 hormonal therapy 49 aortic coarctation 49 pT2 49 autoimmune pancreatitis 49 microscopic colitis 49 IDH mutations 49 rtPA 49 distal colon cancer 49 oncogenic mutations 49 RLAI 49 adenoma 49 paroxysmal AF 49 postoperative complication 49 gastric atrophy 49 vaginal hysterectomy 49 genotypic resistance 49 T1a 49 bladder tumors 49 stage IIIA 49 antimetabolite 49 malignant polyps 49 contralateral breast 49 neoadjuvant therapy 49 KRAS status 49 axillary lymph node dissection 49 cancerdefine 49 molar pregnancy 49 fragility fracture 49 PSA velocity 49 Stage IIB 49 adrenalectomy 49 abdominal ultrasounds 49 taxane therapy 49 melanoma lesions 49 debilitating neurodegenerative disorder 49 heartburn GERD 49 hepatectomy 49 prednisone steroid 49 PSADT 49 interferon ribavirin 49 refractory ischemia 48 undergo lumpectomy 48 thrombo embolic 48 leiomyomas 48 sarcomatoid 48 neurodevelopmental outcomes 48 Ewing sarcoma bone 48 venous thromboembolic disease 48 noncancerous prostate 48 colorectal polyps 48 colonic polyps 48 extracapsular extension 48 cancerous ovary 48 poor metabolizers 48 colon tumors 48 conventional angiography 48 undergone radical prostatectomy 48 undergoing cardiac catheterization 48 precancerous lesion 48 familial ALS 48 prophylactic cranial irradiation 48 complete cytogenetic response 48 polyps growths 48 cerebri 48 atrial enlargement 48 EBRT 48 Waldenstrom macroglobulinemia 48 pre cancerous polyps 48 yearly mammogram 48 prostate carcinogenesis 48 ADPKD 48 recurrent UTI 48 breast lumps 48 chorioamnionitis 48 phenothiazines 48 comorbid anxiety 48 appendiceal 48 benign breast 48 advanced neoplasia 48 impotence incontinence 48 parathyroidectomy 48 cytotoxic therapy 48 urolithiasis 48 Daytime sleepiness 48 colon polyps 48 diagnostic mammogram 48 abdominal hysterectomy 48 resected pancreatic cancer 48 non mutated KRAS 48 carcinoid tumor 48 untreated OSA 48 distal colon 48 cancerous polyps 48 galiximab 48 node dissection 48 mCRC patients 48 testicular shrinkage 48 underarm lymph nodes 48 clodronate 48 hormone therapy 48 recurrent NSCLC 48 uterine fibroid 48 Wilms tumors 48 precancerous cervical 48 colorectal carcinoma 48 glandular tissue 48 erythema nodosum 48 APTIVUS r 48 osteosarcomas 48 prostate specific 48 standard chemotherapy regimen 48 uterine tumors 48 anterior uveitis 48 atypical fractures 48 Leydig cell 48 defects mental retardation 48 Benign tumors 48 obstructive coronary 48 impair cognition 48 bullous 48 Uveal melanoma 48 Surgical excision 48 ß blockers 48 undergo radical prostatectomy 48 skeletal metastases 48 recurrent glioblastoma 48 enucleation 48 sociodemographic characteristics 48 hepatic toxicity 48 undertreating 48 DEXA scan 48 cytoreduction 48 chemically alters 48 abruption 48 multimodality therapy 48 Acute pancreatitis 48 epithelial ovarian cancer 48 hormonal treatments 48 curative resection 48 ovulatory cycles 48 metastasized melanoma 48 corticosteroid therapy 48 advanced epithelial ovarian 48 anthracycline chemotherapy 48 chemo therapy 48 IV bisphosphonates 48 renal insufficiency 48 bile duct cancers 48 immunosuppressive medication 48 asymptomatic PAD 48 NUCYNTA ™ 48 uterus hysterectomy 48 gp# vaccine 48 stage IIIB IV 48 hyper IgE syndrome 48 hormone therapy estrogen 48 cancerous lumps 48 ER CHOP 48 deep vein thromboses 48 intensive statin therapy 48 recurrent ischemia 48 Circulating tumor cells 48 neurocognitive deficits 48 paroxetine sertraline 48 brain lesions 48 chlamydial infection 48 Kaklamani 48 recurrent venous thromboembolism 48 malignant cancerous 48 fibroid embolization 48 previously untreated follicular 48 glomerular filtration 48 mTOR inhibition 48 echocardiographic parameters 48 biochemical recurrence 48 allogeneic HSCT 48 System IPSS 48 upper gastrointestinal endoscopy 48 metastatic lung cancer 48 metastatic kidney 48 ULTRAM ER 48 aneurysmal subarachnoid hemorrhage 48 radiographic findings 48 immune reconstitution syndrome 48 radiotherapy chemotherapy 48 underwent liver transplantation 48 Plantar warts 48 Tasigna prolongs 48 IV malignant melanoma 48 neurocognitive impairment 48 recurrent myocardial infarction 48 bilateral orchiectomy 48 subsyndromal 48 leptin deficiency 48 histologically confirmed 48 breast carcinoma 48 anaplastic 48 anticlotting drugs 48 bronchopulmonary dysplasia BPD 48 esophageal carcinoma 48 Platinol ® cisplatin 48 refractory metastatic 48 Refractory Hodgkin Lymphoma 48 para aortic 48 prolongs survival 48 intraperitoneal therapy 48 lymphocytic leukemia 48 noncardiac surgery 48 antiplatelet drugs 48 colon rectal cancer 48 severe renal impairment 48 renal scarring 48 neoadjuvant radiation 48 pulmonary metastasis 48 cystectomy 48 pulmonary toxicity 48 Raynaud syndrome 48 artery stenosis 48 testicular cancers 47 preventive mastectomy 47 pelvic prolapse 47 chronic migraine headaches 47 paclitaxel cisplatin 47 cryptogenic stroke 47 screening colonoscopy 47 metastatic adenocarcinoma 47 fibrinolysis 47 adjuvant therapy 47 Radical prostatectomy 47 Immunosuppressive drugs 47 distal radial fractures 47 parkinsonian symptoms 47 benign prostatic hyperplasia enlarged 47 nocebo 47 gallstone formation 47 polyp detection 47 Radiofrequency ablation 47 HBeAg negative 47 orchidectomy 47 acute promyelocytic leukemia 47 receiving ISENTRESS 47 nonoperative treatment 47 puerperal psychosis 47 polyarticular 47 postoperative infections 47 ticlopidine 47 annualized relapse 47 recurrent GBM 47 diagnostic workup 47 spondylolysis 47 attain statistical significance 47 abnormal cervical 47 potentially hepatotoxic 47 affective psychosis 47 osteoporotic compression fractures 47 fibrocystic breasts 47 Kaplan Meier 47 locoregional 47 amenorrhoea 47 pancreatic resection 47 FDG-PET/CT 47 abdominal ultrasound 47 estimated glomerular filtration 47 prognostic variables 47 node metastases 47 platelet clumping 47 T1c 47 tumor metastases 47 prostate cancer PCa 47 undergone mastectomy 47 precursor lesions 47 ischemia induced 47 endogenous cannabinoids 47 BRCA gene mutations 47 impaired cognition 47 BRCA mutations 47 nonpsychotic 47 anastomotic leak 47 anticholinergic agents 47 letrozole 47 fibroadenoma 47 Contralateral 47 Crohns disease 47 symptomatic atrial fibrillation 47 colorectal polyp 47 pelvic irradiation 47 MS relapses 47 EGFR TKI 47 pegylated liposomal doxorubicin 47 ipsilateral breast 47 HER2 positive metastatic 47 invasive diagnostic 47 clinically detectable 47 lymphatic tissue 47 esophageal spams 47 cervical lesions 47 radiochemotherapy 47 de ath 47 pulmonary exacerbation 47 proximal colon 47 atypical lobular hyperplasia 47 fine needle aspiration 47 symptomatic fibroids 47 angiosarcoma 47 Postoperative complications 47 cancer mCRC 47 overt hepatic encephalopathy HE 47 invasive biopsy 47 Chronic Myeloid Leukaemia 47 external beam radiotherapy 47 temozolomide 47 removed laparoscopically 47 liver decompensation 47 HIV tropism 47 AChE inhibitors 47 obstructive coronary artery 47 dysplastic lesions 47 recurrent VTE 47 adjuvant therapies 47 Severe acne 47 baseline LDH 47 mycophenolate mofetil 47 imatinib therapy 47 incurable prostate 47 pre cancerous lesion 47 mastectomy chemotherapy 47 contralateral breast cancer 47 Thal Dex 47 axillary lymph node 47 nocebo effect 47 nortriptyline Pamelor 47 noncancer pain 47 familial polyposis 47 acetabular fractures 47 infiltrating ductal carcinoma 47 Myelodysplastic Syndrome 47 Chlamydia psittaci 47 oophorectomy removal 47 fallopian tube cancers 47 metastatic renal 47 BRCA1 mutation carriers 47 postoperative morbidity 47 ECD kidneys 47 Postoperatively 47 shrink cancerous tumors 47 aneurysm rupture 47 mucinous 47 pre malignant lesions 47 persistent pulmonary hypertension 47 ixabepilone 47 severe neutropenia 47 Kaplan Meier curve 47 severe hepatic dysfunction 47 painless lump 47 taxane chemotherapy 47 gonadotrophin releasing hormone 47 femoral neck fracture 47 pelvic ultrasound 47 GH deficiency 47 distant metastasis 47 MMSE score 47 gemcitabine chemotherapy 47 transplanted islets 47 radical cystectomy 47 HER2 positive tumors 47 ischemic vascular 47 ovarian dysfunction 47 Eliezer Zomer Ph.D. 47 thoracoscopic lobectomy 47 zoledronic acid 47 severe hypoglycaemia 47 abnormal lipid levels 47 antiarrhythmics 47 concomitant antibiotics 47 noncancerous tumors 47 Sentinel Lymph Node Biopsy 47 anthracycline containing 47 paraganglioma 47 Optic nerve 47 intracerebral haemorrhage 47 prolonged QT interval 47 hypercoagulability 47 abstinent alcoholics 47 underwent radical prostatectomy 47 gastric carcinoma 47 neuronal dysfunction 47 tumoral 47 chemoradiation 47 Multivariate analyzes 47 sentinel nodes 47 neurodevelopmental impairment 47 neoadjuvant 47 malignant brain 47 axillary lymph nodes 47 hsCRP levels 47 DES implantation 47 Hemorrhagic strokes 47 dobutamine 47 preventive mastectomies 47 serum urate levels 47 arterial stenosis 47 aminotransferase levels 47 angiographically 47 thromboembolic complications 47 proliferative diabetic retinopathy 47 pelvic radiotherapy 47 embolic stroke 47 autoantibody levels 47 bladder cancers 47 symptomatic hyponatremia 47 incisional biopsy 47 reintervention 47 pheochromocytoma 47 refractory ALCL 47 propranolol Inderal 47 thymectomy 47 bone metastasis 47 clinically meaningful differences 47 SLNB 47 FOLFOX6 47 preoperative PSA 47 rechallenge 47 skin sparing mastectomy 47 PROSTVAC VF 47 bone marrow biopsies 47 medulla blastoma 47 amisulpride 46 dalteparin 46 diffuse intrinsic pontine glioma 46 asymptomatic AF 46 GI bleeds 46 Rectal cancer 46 myocardial infarctions MI 46 primitive neuroectodermal tumors 46 acetabular fracture 46 glial tumors 46 QT intervals 46 % CI #.#-#.# [003] 46 tryptophan depletion 46 metastatic basal cell 46 microvascular angina 46 subclinical atherosclerosis 46 multivariable analysis 46 clinicopathological 46 CMV infection 46 neuropsychological deficits 46 clinicopathological features 46 prophylactic mastectomy 46 premenopausal breast cancer 46 metastatic bone 46 tubal pregnancy 46 thymic carcinoma 46 revascularizations 46 bisphosphonate therapy 46 nonsmall cell lung cancer 46 CIN3 46 placental malaria 46 adjuvant tamoxifen 46 pre cancerous growths 46 VTEs 46 endosonography 46 breast conserving lumpectomy 46 acute mania 46 uterine cancers 46 neurologic complications 46 coinfected patients 46 contralateral prophylactic mastectomy 46 colorectal cancer liver metastases 46 reblockage 46 SSRI antidepressant 46 anatomical abnormalities 46 renal allograft 46 reoccurance 46 metabolic disturbances 46 abnormal genital 46 dysfunction Zada 46 pT3 46 Gall bladder 46 cancerous lesion 46 insulin secretagogues 46 Shark cartilage 46 QRS interval 46 primary hyperparathyroidism 46 vaginal progesterone gel 46 physiological abnormalities 46 Fatty liver 46 chemo radiotherapy 46 benign polyps 46 abnormal Pap 46 thromboembolism 46 localized renal 46 Metastatic colorectal cancer 46 Kalantar Zadeh 46 median survivals 46 systolic dysfunction 46 undetectable PSA 46 adenomatous polyp 46 Accelerated Partial Breast Irradiation 46 dopaminergic therapy 46 Personality traits 46 androgen depletion 46 prospectively stratified 46 sarcoid 46 lymph node metastasis